About QUIBIM S.L.
Quibim S.L. is a medical imaging AI company that develops pioneering radiomics technology and software-as-a-medical-device solutions to unlock insights from imaging data and improve patient outcomes. The company has built a comprehensive cloud-based, tissue-agnostic platform that extracts key radiomics drivers from large-scale imaging data registries, enabling precision medicine applications across oncology, neurology, and other therapeutic areas. Quibim's product portfolio includes regulatory-cleared medical devices for clinical use: QP-Prostate for automated prostate MRI analysis with PI-RADS compliance, QP-Brain for brain volumetry and white matter hyperintensity analysis, QP-Liver for quantifying hepatic fat and iron concentration, and QP-Insights for comprehensive multi-omics data management and radiomics research. These solutions integrate seamlessly with existing PACS systems through QP-Link, providing automated workflows that deliver quantitative, standardized reports directly to clinical systems. The company serves three primary markets: healthcare providers seeking to enhance diagnostic accuracy and workflow efficiency, biopharma companies accelerating drug development programs through imaging biomarkers, and research institutions conducting clinical studies. Quibim's platform manages over 100,000 de-identified cancer patient records and millions of research imaging datasets, with deployment across multiple international sites. The technology emphasizes data security with ISO 27001:2022 certification, HIPAA and GDPR compliance, and encryption at rest and in transit on Microsoft Azure's cloud infrastructure. Quibim partners with leading healthcare institutions and pharmaceutical companies to extract real-world evidence and develop prognostic and predictive models. The company's radiomics approach provides detailed quantitative insights beyond traditional imaging methods, supporting personalized treatment planning, patient stratification for clinical trials, and monitoring of treatment response and adverse events.
Clinical Focus
Medical conditions and clinical areas addressed by QUIBIM S.L..
Who It Serves
Milestones & Awards
Recent Milestones
QP-Prostate received Health Canada licence (June 2026), selected for New York strategic AI program (May 2026), partnership with Vara to bring breast cancer screening AI to Spain (April 2026)
Awards & Recognition
Only healthtech selected by New York for strategic AI program, grants and awards mentioned but not detailed
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.